NCT03851068View on ClinicalTrials.gov

Early Feasibility Study for the Foldax Tria Aortic Heart Valve

NAActive, not recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 18, 2019

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2026

Conditions
Aortic Valve DiseaseAortic Valve Stenosis
Interventions
DEVICE

Foldax Tria Aortic Valve

Aortic Valve Replacement

Trial Locations (5)

43214

OhioHealth Riverside, Columbus

46290

St. Vincent Hospital, Indianapolis

48073

William Beaumont Hospital, Detroit

67214

Ascension Via Christi St. Francis Hospital, Wichita

84219

The Christ Hospital, Cincinnati

Sponsors

Lead Sponsor

Foldax, Inc
All Listed Sponsors
lead

Foldax, Inc

INDUSTRY